BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 7, 2026
Home
»
Authors
» Jennifer Boggs
Jennifer Boggs
Articles
ARTICLES
Cleveland BioLabs Files $14M IPO For Radiation Protection
Feb. 23, 2006
By
Jennifer Boggs
Precision’s Series B Adds $20M For Cancer Regimen
Feb. 22, 2006
By
Jennifer Boggs
Precision’s Series B Adds $20M For Cancer Regimen
Feb. 22, 2006
By
Jennifer Boggs
QLT's BPH drug doesn't show efficacy in Phase II study
Feb. 21, 2006
By
Jennifer Boggs
QLT’s BPH Drug Fails To Show Efficacy In Phase II
Feb. 17, 2006
By
Jennifer Boggs
QLT’s BPH Drug Fails To Show Efficacy In Phase II
Feb. 17, 2006
By
Jennifer Boggs
Australia’s G2 Enters Novo Deal Valued At Up To $102M
Feb. 16, 2006
By
Jennifer Boggs
Australia’s G2 Enters Novo Deal Valued At Up To $102M
Feb. 16, 2006
By
Jennifer Boggs
YM’s Direct Offering Raises $40M For Drug Development
Feb. 15, 2006
By
Jennifer Boggs
YM’s Direct Offering Raises $40M For Drug Development
Feb. 15, 2006
By
Jennifer Boggs
View All Articles by Jennifer Boggs
